Protocol No.: E4412

Title
A Phase I Study with an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma
Principal Investigator
Veltri, Lauren
Phase
I/II
Age Group
Adult
Applicable Disease Site
Lymphoma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Vicky Lynn, RN
Research Nurse
Phone: +1 304-293-8407

View on ClinicalTrials.gov